Bin1 mediates apoptosis by c-Myc in transformed primary cells
- PMID: 11306501
Bin1 mediates apoptosis by c-Myc in transformed primary cells
Abstract
The Bin1 gene encodes a c-Myc-interacting adapter protein with tumor suppressor and cell death properties. In this study, we offer evidence that Bin1 participates in a mechanism through which c-Myc activates programmed cell death in transformed primary chick or rat cells. Antisense or dominant inhibitory Bin1 genes did not affect the ability of c-Myc to drive proliferation or transformation, but they did reduce the susceptibility of cells to c-Myc-induced apoptosis. Protein-protein interaction was implicated, suggesting that Bin1 mediates a death or death sensitization signal from c-Myc. Our findings offer direct support for the "dual signal" model of Myc apoptotic function, based on interactions with a binding protein. Loss of Bin1 in human tumors may promote malignant progression in part by helping to stanch the death penalty associated with c-Myc activation.
Similar articles
-
The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.Oncogene. 2000 Sep 28;19(41):4669-84. doi: 10.1038/sj.onc.1203681. Oncogene. 2000. PMID: 11032017
-
Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.Oncogene. 2003 Jun 5;22(23):3578-88. doi: 10.1038/sj.onc.1206481. Oncogene. 2003. PMID: 12789266
-
Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.J Cell Physiol. 2008 Sep;216(3):621-31. doi: 10.1002/jcp.21437. J Cell Physiol. 2008. PMID: 18348166
-
Mechanisms of apoptosis by c-Myc.Oncogene. 1999 May 13;18(19):2967-87. doi: 10.1038/sj.onc.1202727. Oncogene. 1999. PMID: 10378693 Review.
-
The proto-oncogene c-myc in hematopoietic development and leukemogenesis.Oncogene. 2002 May 13;21(21):3414-21. doi: 10.1038/sj.onc.1205400. Oncogene. 2002. PMID: 12032779 Review.
Cited by
-
New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors.Int J Mol Sci. 2021 Dec 11;22(24):13324. doi: 10.3390/ijms222413324. Int J Mol Sci. 2021. PMID: 34948122 Free PMC article.
-
The splicing factor RBM25 controls MYC activity in acute myeloid leukemia.Nat Commun. 2019 Jan 11;10(1):172. doi: 10.1038/s41467-018-08076-y. Nat Commun. 2019. PMID: 30635567 Free PMC article.
-
The gene encoding the splicing factor SF2/ASF is a proto-oncogene.Nat Struct Mol Biol. 2007 Mar;14(3):185-93. doi: 10.1038/nsmb1209. Epub 2007 Feb 18. Nat Struct Mol Biol. 2007. PMID: 17310252 Free PMC article.
-
Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors.Cell Cycle. 2012 May 15;11(10):1956-65. doi: 10.4161/cc.20280. Epub 2012 May 15. Cell Cycle. 2012. PMID: 22544318 Free PMC article.
-
Targeted disruption of the murine Bin1/Amphiphysin II gene does not disable endocytosis but results in embryonic cardiomyopathy with aberrant myofibril formation.Mol Cell Biol. 2003 Jun;23(12):4295-306. doi: 10.1128/MCB.23.12.4295-4306.2003. Mol Cell Biol. 2003. PMID: 12773571 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources